Study to Evaluate the Safety of Post-Operative TZP-101 (IV Ulimorelin) After Partial Bowel Resection
NCT01710982
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Postoperative Ileus
Interventions
DRUG:
TZP-101
OTHER:
Placebo
Sponsor
Norgine